LEVALBUTEROL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for levalbuterol hydrochloride and what is the scope of freedom to operate?
Levalbuterol hydrochloride
is the generic ingredient in two branded drugs marketed by Cipla, Impax Labs Inc, Luoxin Aurovitas, Mylan Speciality Lp, Ritedose Corp, Sun Pharm, Teva Parenteral, Teva Pharms Usa, and Hikma, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for levalbuterol hydrochloride. Eleven suppliers are listed for this compound.
Summary for LEVALBUTEROL HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 9 |
NDAs: | 11 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Clinical Trials: | 33 |
Patent Applications: | 1,504 |
What excipients (inactive ingredients) are in LEVALBUTEROL HYDROCHLORIDE? | LEVALBUTEROL HYDROCHLORIDE excipients list |
DailyMed Link: | LEVALBUTEROL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for LEVALBUTEROL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Aleppo | Phase 4 |
Children's Hospital Los Angeles | N/A |
University of Illinois at Chicago | N/A |
Pharmacology for LEVALBUTEROL HYDROCHLORIDE
Drug Class | beta2-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta2-Agonists |
Paragraph IV (Patent) Challenges for LEVALBUTEROL HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
XOPENEX | Inhalation Solution | levalbuterol hydrochloride | 0.25% | 020837 | 1 | 2006-05-23 |
XOPENEX | Inhalation Solution | levalbuterol hydrochloride | 0.0103%, 0.021% and 0.042% | 020837 | 1 | 2005-06-20 |
US Patents and Regulatory Information for LEVALBUTEROL HYDROCHLORIDE
Expired US Patents for LEVALBUTEROL HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hikma | XOPENEX | levalbuterol hydrochloride | SOLUTION;INHALATION | 020837-003 | Jan 30, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Hikma | XOPENEX | levalbuterol hydrochloride | SOLUTION;INHALATION | 020837-004 | Jul 18, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Hikma | XOPENEX | levalbuterol hydrochloride | SOLUTION;INHALATION | 020837-002 | Mar 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Hikma | XOPENEX | levalbuterol hydrochloride | SOLUTION;INHALATION | 020837-002 | Mar 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Hikma | XOPENEX | levalbuterol hydrochloride | SOLUTION;INHALATION | 020837-003 | Jan 30, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Hikma | XOPENEX | levalbuterol hydrochloride | SOLUTION;INHALATION | 020837-002 | Mar 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.